Ignoring Emerging Infectious Diseases: The Fatal Error That Could Lead to the Next Pandemic
Keywords:
Emerging Infectious Diseases, Pandemic Preparedness, Vaccines, EpidemiologyAbstract
-
Emerging Infectious Diseases (EIDs) are a group of novel or re-surging infectious pathogens which primarily originate from animal populations.
-
Many EIDs have a pandemic-causing ability and should be a top priority for governments worldwide.
-
The primary strategies that should be implemented to prevent a pandemic caused by emerging pathogens revolve around preventing the transfer of zoonoses via diligent surveillance methods involving classical tools, data science, and artificial intelligence.
-
The equitable use of mRNA vaccine templates can decrease the spread, morbidity, and mortality of viral and possibly other pathogenic EIDs.
-
Governments must invest in creating stable healthcare systems and well-equipped research facilities to handle the burden of EID outbreaks.
References
The world is not prepared for pandemic flu, says WHO director [Internet] Euronews.com. 2010 [cited 2021 Nov 25]. Available from: https://www. euronews.com/2019/10/10/the-world-is-not-ready-for-pandemic-flu- says-who-director.
COVID-19 map – Johns Hopkins Coronavirus Resource Centre [Internet]. JHU.edu. [cited 2021 Nov 25]. Available from: https://coronavirus.jhu. edu/map.html.
Head MG, Brown RJ, Newell M-L, Scott JAG, Batechlor J, Atun R. The allocation of US dollar; 105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments. Lancet Glob Health. 2020;8(10):e1295-304. doi: https://doi.org /10.1016/S2214-109X(20)30357-0.
Nelson AM. The cost of disease eradication. Smallpox and bovine tuberculosis. Ann N Y Acad Sci. 1999;894(1):83-91. doi:10.1111/j.1749-6632.1999.tb08048.x.
National Institute of Allergy and Infecitous Diseases. NIAID emerging infectious diseases/pathogens [Internet]. 2022 [cited 2021 Nov 27]. Available from: https://www.niaid.nih.gov/research/emerging-infectious- diseases-pathogens.
Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature. 2007;447(7142):279-83. doi:10.1038/nature05775.
Baker, R.E., Mahmud, A.S., Miller, I.F. et al. Infectious disease in an era of global change. Nat Rev Microbiol. 20:193–205 (2022). doi:10.1038/s41579- 021-00639-z
Allen T, Murray KA, Zambrana-Torrelio C, Morse SS, Rondrinini C, Di Marco M, et al. Global hotspots and correlates of emerging zoonotic diseases. Nat Commun. 2017;8(1):1-10. doi: 10.1038/s41467-017-00923-8.
Kolby J. To prevent the next pandemic, it’s the legal wildlife trade we should worry about [Internet]. National Geographic; 2020 [cited 2020 Nov 29]; Available from: https://www.nationalgeographic.com/animals/ article/to-prevent-next-pandemic-focus-on-legal-wildlife-trade
Maxmen A. WHO report into COVID pandemic origins zeroes in on animal markets, labs. Nature. 2021;592(7853):173-4. 10.1038/d41586-021-00865-8.
Shiferaw ML, Doty JB, Maghlakelidze G, Morgan J, Khamaladze E, Parkadze O, et al. Frameworks for preventing, detecting, and controlling zoonotic diseases. Emerg Infect Dis. 2017;23(13):71-76. doi: 10.3201/ eid2313.170601.
Ellwanger JF, Kaminski V de L, Chies JAB. Emerging infectious disease prevention: Where should we invest our resources and efforts? J Infect Public Health. 2019;12(3):313-6. doi: 10.1016/j.jiph.2019.03.010.
Quipeng. 2022 Data science approaches to infectious disease surveillance. Phil Tran. R Soc. A.3802021011520210115
Akinyi MY, Kivai S, Mbuthia P, Kiragu D, Wango T, Shikoli C, et al. Surveillance of emerging infectious diseases in wild non-human primates in Kenya: Successes and challenges [Preprint]. Research Square. 2021:1-42. doi:10.21203/rs.3.rs-923002/v1.
Zeng D, Cao Z, Neill DB. Chapter 22 - Artificial intelligence–enabled public health surveillance—from local detection to global epidemic monitoring and control. Academic Press. 2021:437-453.
Spillover Global. Spillover [Internet]. 2021 [cited 2021 Nov 27]. Available from: https://spillover.global.
Sandbrink JB, Shattock RJ. RNA vaccines: A suitable platform for tackling emerging pandemics? Front Immunol. 2020;11:608460. doi: 10.3389/ fimmu.2020.608460.
Wang Y, Zhang Z, Luo J. et al. mRNA vaccine: a potential therapeutic strategy. Mol Cancer. 2021;20(1):33 (2021). doi:10.1186/s12943-021- 01311-z
Excler JL, Saville M, Berkley S. et al. Vaccine development for emerging infectious diseases. Nat Med. 2021;27(4): 591–600 (2021). doi:10.1038/ s41591-021-01301-0
Kavanagh MM, Gostin LO, Sunder M. Sharing technology and vaccine doses to address global vaccine inequity and end the COVID-19 pandemic. JAMA. 2021;326(3):219-20. doi: 10.1001/jama.2021.10823.
United Nations. So much more that we can do to save lives right now. 2021 [cited 2021 Nov 30]; Available from: https://www.un.org/en/awake- at-night/S4-E8-so-much-more-we-can-do-to-save-lives-right-now.
Coccia, M. Pandemic Prevention: Lessons from COVID-19. Encyclopedia. 2021;1:433-444. doi:10.3390/encyclopedia1020036
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Karlo Vidovic
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.
